Skip to main content
Clinical Trials/NCT01938313
NCT01938313
Completed
Phase 2

Comparison of ERAS (Early Recovery After Surgery) Protocol With Conventional Protocol After Laparoscopic Gastrectomy: A Prospective Randomized Controlled Trial (Phase II Study))

Seoul National University Bundang Hospital1 site in 1 country100 target enrollmentAugust 2012
ConditionsGastric Cancer

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Gastric Cancer
Sponsor
Seoul National University Bundang Hospital
Enrollment
100
Locations
1
Primary Endpoint
Recovering Rate
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Enhanced Recovery After Surgery (ERAS) programs have been introduced with purposes of reducing the surgical stress response and obtaining optimal recovery after surgery.

Detailed Description

There is strong evidence of the usefulness of the ERAS programs in patients undergoing colorectal surgery in terms of significantly reduced postoperative complications and shorter length of hospital stay, compared to the patients of conventional treatment. However, few studies exist about the implication of ERAS programs in the laparoscopic gastrectomy. The aim of this study was to compare the recovery rate, morbidity, and quality of life in the patients undergoing laparoscopic gastrectomy for gastric cancer, receiving either ERAS protocol or conventional postoperative cares.

Registry
clinicaltrials.gov
Start Date
August 2012
End Date
April 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hyung-Ho Kim

Professor

Seoul National University Bundang Hospital

Eligibility Criteria

Inclusion Criteria

  • Elective surgery
  • American Society of Anesthesiologists (ASA) scores \< 3
  • 20 \< Age \< 80
  • Gastric cancer, adenocarcinoma, possible to perform laparoscopic distal gastrectomy
  • Informed consent
  • No other treatment (Radiation, Chemotherapy or Immunotherapy) on this gastric cancer or other type of cancer.
  • No systemic inflammatory disease

Exclusion Criteria

  • Emergency operation

Outcomes

Primary Outcomes

Recovering Rate

Time Frame: 4 days after surgery

1. Tolerance of diet for 24 hours A. Able to eat one third of more of soft-blend meal without abdominal discomfort, bloating, nausea, or vomiting 2. Analgesic-free (oral or IV analgesic drugs not necessary after cessation of PCA) 3. Safe ambulation (ambulation of 600m without assistance) 4. Afebrile status without major complications (fever defined as body temperature greater than 37.5) * Above total 4 criteria should be satisfied for the evaluation of complete recovery.

Secondary Outcomes

  • Postoperative length of hospital stay(up to 4 weeks after surgery)
  • Time to tolerance of a full diet(up to 1 month after surgery)
  • Complications during the admissionTime to first bowel motion(up to 30 days after surgery)
  • Quality of life(up to 1 month after surgery)
  • Readmission rate(up to 30 days after surgery)
  • Time to first bowel motion Time to first bowel motion(up to 7 days after surgery)
  • Pain scores based on a visual analog scale the day of surgery and the subsequent 3 days(up to 3 days after surgery)

Study Sites (1)

Loading locations...

Similar Trials